© 2023 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Pregnancy and Birth
Active postnatal care associated with periviable infant survival rate
January 27, 2023
In a recent study, the infant survival rate among periviable infants varied based on the type of active postnatal care received at certain gestational ages.
FDA advisory panel votes to withdraw approval of premature birth prevention drug
October 19, 2022
An advisory panel for the US Food and Drug Administration voted 14-1 to withdraw 17α-hydroxyprogesterone caproate (Makena; Covis Pharma) from the market.
March of Dimes launches new preterm birth research center at UCSF
August 24, 2022
Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.
Prenatal exposure to endocrine-disrupting chemicals increases risk of liver injury
July 14, 2022
There was an increased odds of liver injury per exposure-mixture quartile increase for organochlorine pesticides, PBDEs) perfluoroalkyl substances, and metals.
Researchers investigate psoriasis and adverse pregnancy outcomes
July 14, 2022
A study published in JAAD International examined the association between psoriasis and adverse pregnancy outcomes (APOs) and found that providers should be on the lookout for ectopic pregnancies (EP) in this population.
Hypertension disorders of pregnancy linked to worsened risk of chronic hypertension later in life
July 06, 2022
Gregory Weiss, MD, provides perspective on a recent study suggesting women with gestational hypertension were at an increased risk of chronic hypertension later in life.
An update on the presentation, nosology, and causes of postpartum psychosis
June 17, 2022
Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
Hidradenitis suppurativa in pregnancy
June 09, 2022
This painful skin disease may lower the odds of live birth and trigger comorbidities.
IVIG safe, effective for treating pregnant patients with severe COVID-19
May 18, 2022
Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.
Telehealth: a brave new world for ob-gyns
May 08, 2022
At the 2022 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting, one health care provider shows the burgeoning terrain in telehealth options for both practitioner and patient.